Clinical implementation of MR-guided vaginal cylinder brachytherapy

Amir M. Owrangi, Shruti Jolly, James M. Balter, Yue Cao, Katherine E. Maturen, Lisa Young, Tong Zhu, Joann I. Prisciandaro

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

We present an institutional experience on the clinical implementation of magnetic resonance (MR)-guided vaginal brachytherapy using commercially available solid applicator models. To test the fidelity of solid applicator models to digitize vaginal cylinder applicators, three datasets were evaluated. The first included 15patients who were simulated with CT alone. Next, a water phantom was used to evaluate vaginal cylinders ranging from 20 to 35 mm in diameter with CT and MR. Finally, three patients undergoing HDR brachytherapy with vaginal cylinders that were simulated with both CT and MR were evaluated. In these assessments, the solid applicator models were aligned based on the outline of the applicators on the corresponding volumetric image, and deviations between the central source positions defined based on X-ray markers (on CT) and solid applicator models (on CT and MR), and the percent dose difference between select reference points were calculated. The mean central source deviation defined based on X-ray markers (on CT) and solid applicator models (on CT and MR) for the 15-patient cohort, the phantom, and the 3-patient cohort is 0.6 mm, 0.6 mm, and 1.2 mm, respectively. The average absolute percent dose difference for the bladder, rectum, prescription, and inferior reference points were 2.2%, 2.3%, 2.2%, and 2.4%, respectively, for the 15 patient cohort. For the phantom study, the average, absolute percent dose difference for the prescription and inferior reference points are 2.0% and 2.1% for the CT, 2.3% and 2.2% for the T1W, and 2.8% and 3.0% for the T2W images. For the three patient cohort, the average absolute percent dose difference for the bladder, rectum, prescription, and inferior reference points are 2.9%, 2.6%, 3.0%, and 4.2% for the CT, 6.5%, 1.6%, 2.5%, and 4.7% for the T1W, and 6.0%, 7.4%, 2.6, and 2.0% for the T2W images. Based on the current study, aligning the applicator model to MR images provides a practical, efficient approach to perform MR-based brachytherapy planning.

Original languageEnglish (US)
Pages (from-to)490-500
Number of pages11
JournalJournal of Applied Clinical Medical Physics
Volume16
Issue number6
StatePublished - Jan 1 2015

Fingerprint

Applicators
Brachytherapy
Magnetic resonance
magnetic resonance
Magnetic Resonance Spectroscopy
Prescriptions
rectum
dosage
bladder
Rectum
markers
Urinary Bladder
X-Rays
deviation
X rays
planning
x rays
Water
Planning
water

Keywords

  • Applicator reconstruction
  • Brachytherapy
  • MRI

ASJC Scopus subject areas

  • Radiation
  • Instrumentation
  • Radiology Nuclear Medicine and imaging

Cite this

Owrangi, A. M., Jolly, S., Balter, J. M., Cao, Y., Maturen, K. E., Young, L., ... Prisciandaro, J. I. (2015). Clinical implementation of MR-guided vaginal cylinder brachytherapy. Journal of Applied Clinical Medical Physics, 16(6), 490-500.

Clinical implementation of MR-guided vaginal cylinder brachytherapy. / Owrangi, Amir M.; Jolly, Shruti; Balter, James M.; Cao, Yue; Maturen, Katherine E.; Young, Lisa; Zhu, Tong; Prisciandaro, Joann I.

In: Journal of Applied Clinical Medical Physics, Vol. 16, No. 6, 01.01.2015, p. 490-500.

Research output: Contribution to journalArticle

Owrangi, AM, Jolly, S, Balter, JM, Cao, Y, Maturen, KE, Young, L, Zhu, T & Prisciandaro, JI 2015, 'Clinical implementation of MR-guided vaginal cylinder brachytherapy', Journal of Applied Clinical Medical Physics, vol. 16, no. 6, pp. 490-500.
Owrangi AM, Jolly S, Balter JM, Cao Y, Maturen KE, Young L et al. Clinical implementation of MR-guided vaginal cylinder brachytherapy. Journal of Applied Clinical Medical Physics. 2015 Jan 1;16(6):490-500.
Owrangi, Amir M. ; Jolly, Shruti ; Balter, James M. ; Cao, Yue ; Maturen, Katherine E. ; Young, Lisa ; Zhu, Tong ; Prisciandaro, Joann I. / Clinical implementation of MR-guided vaginal cylinder brachytherapy. In: Journal of Applied Clinical Medical Physics. 2015 ; Vol. 16, No. 6. pp. 490-500.
@article{9f648c47951745409b0a9ea19c67c19a,
title = "Clinical implementation of MR-guided vaginal cylinder brachytherapy",
abstract = "We present an institutional experience on the clinical implementation of magnetic resonance (MR)-guided vaginal brachytherapy using commercially available solid applicator models. To test the fidelity of solid applicator models to digitize vaginal cylinder applicators, three datasets were evaluated. The first included 15patients who were simulated with CT alone. Next, a water phantom was used to evaluate vaginal cylinders ranging from 20 to 35 mm in diameter with CT and MR. Finally, three patients undergoing HDR brachytherapy with vaginal cylinders that were simulated with both CT and MR were evaluated. In these assessments, the solid applicator models were aligned based on the outline of the applicators on the corresponding volumetric image, and deviations between the central source positions defined based on X-ray markers (on CT) and solid applicator models (on CT and MR), and the percent dose difference between select reference points were calculated. The mean central source deviation defined based on X-ray markers (on CT) and solid applicator models (on CT and MR) for the 15-patient cohort, the phantom, and the 3-patient cohort is 0.6 mm, 0.6 mm, and 1.2 mm, respectively. The average absolute percent dose difference for the bladder, rectum, prescription, and inferior reference points were 2.2{\%}, 2.3{\%}, 2.2{\%}, and 2.4{\%}, respectively, for the 15 patient cohort. For the phantom study, the average, absolute percent dose difference for the prescription and inferior reference points are 2.0{\%} and 2.1{\%} for the CT, 2.3{\%} and 2.2{\%} for the T1W, and 2.8{\%} and 3.0{\%} for the T2W images. For the three patient cohort, the average absolute percent dose difference for the bladder, rectum, prescription, and inferior reference points are 2.9{\%}, 2.6{\%}, 3.0{\%}, and 4.2{\%} for the CT, 6.5{\%}, 1.6{\%}, 2.5{\%}, and 4.7{\%} for the T1W, and 6.0{\%}, 7.4{\%}, 2.6, and 2.0{\%} for the T2W images. Based on the current study, aligning the applicator model to MR images provides a practical, efficient approach to perform MR-based brachytherapy planning.",
keywords = "Applicator reconstruction, Brachytherapy, MRI",
author = "Owrangi, {Amir M.} and Shruti Jolly and Balter, {James M.} and Yue Cao and Maturen, {Katherine E.} and Lisa Young and Tong Zhu and Prisciandaro, {Joann I.}",
year = "2015",
month = "1",
day = "1",
language = "English (US)",
volume = "16",
pages = "490--500",
journal = "Journal of Applied Clinical Medical Physics",
issn = "1526-9914",
publisher = "American Institute of Physics Publising LLC",
number = "6",

}

TY - JOUR

T1 - Clinical implementation of MR-guided vaginal cylinder brachytherapy

AU - Owrangi, Amir M.

AU - Jolly, Shruti

AU - Balter, James M.

AU - Cao, Yue

AU - Maturen, Katherine E.

AU - Young, Lisa

AU - Zhu, Tong

AU - Prisciandaro, Joann I.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - We present an institutional experience on the clinical implementation of magnetic resonance (MR)-guided vaginal brachytherapy using commercially available solid applicator models. To test the fidelity of solid applicator models to digitize vaginal cylinder applicators, three datasets were evaluated. The first included 15patients who were simulated with CT alone. Next, a water phantom was used to evaluate vaginal cylinders ranging from 20 to 35 mm in diameter with CT and MR. Finally, three patients undergoing HDR brachytherapy with vaginal cylinders that were simulated with both CT and MR were evaluated. In these assessments, the solid applicator models were aligned based on the outline of the applicators on the corresponding volumetric image, and deviations between the central source positions defined based on X-ray markers (on CT) and solid applicator models (on CT and MR), and the percent dose difference between select reference points were calculated. The mean central source deviation defined based on X-ray markers (on CT) and solid applicator models (on CT and MR) for the 15-patient cohort, the phantom, and the 3-patient cohort is 0.6 mm, 0.6 mm, and 1.2 mm, respectively. The average absolute percent dose difference for the bladder, rectum, prescription, and inferior reference points were 2.2%, 2.3%, 2.2%, and 2.4%, respectively, for the 15 patient cohort. For the phantom study, the average, absolute percent dose difference for the prescription and inferior reference points are 2.0% and 2.1% for the CT, 2.3% and 2.2% for the T1W, and 2.8% and 3.0% for the T2W images. For the three patient cohort, the average absolute percent dose difference for the bladder, rectum, prescription, and inferior reference points are 2.9%, 2.6%, 3.0%, and 4.2% for the CT, 6.5%, 1.6%, 2.5%, and 4.7% for the T1W, and 6.0%, 7.4%, 2.6, and 2.0% for the T2W images. Based on the current study, aligning the applicator model to MR images provides a practical, efficient approach to perform MR-based brachytherapy planning.

AB - We present an institutional experience on the clinical implementation of magnetic resonance (MR)-guided vaginal brachytherapy using commercially available solid applicator models. To test the fidelity of solid applicator models to digitize vaginal cylinder applicators, three datasets were evaluated. The first included 15patients who were simulated with CT alone. Next, a water phantom was used to evaluate vaginal cylinders ranging from 20 to 35 mm in diameter with CT and MR. Finally, three patients undergoing HDR brachytherapy with vaginal cylinders that were simulated with both CT and MR were evaluated. In these assessments, the solid applicator models were aligned based on the outline of the applicators on the corresponding volumetric image, and deviations between the central source positions defined based on X-ray markers (on CT) and solid applicator models (on CT and MR), and the percent dose difference between select reference points were calculated. The mean central source deviation defined based on X-ray markers (on CT) and solid applicator models (on CT and MR) for the 15-patient cohort, the phantom, and the 3-patient cohort is 0.6 mm, 0.6 mm, and 1.2 mm, respectively. The average absolute percent dose difference for the bladder, rectum, prescription, and inferior reference points were 2.2%, 2.3%, 2.2%, and 2.4%, respectively, for the 15 patient cohort. For the phantom study, the average, absolute percent dose difference for the prescription and inferior reference points are 2.0% and 2.1% for the CT, 2.3% and 2.2% for the T1W, and 2.8% and 3.0% for the T2W images. For the three patient cohort, the average absolute percent dose difference for the bladder, rectum, prescription, and inferior reference points are 2.9%, 2.6%, 3.0%, and 4.2% for the CT, 6.5%, 1.6%, 2.5%, and 4.7% for the T1W, and 6.0%, 7.4%, 2.6, and 2.0% for the T2W images. Based on the current study, aligning the applicator model to MR images provides a practical, efficient approach to perform MR-based brachytherapy planning.

KW - Applicator reconstruction

KW - Brachytherapy

KW - MRI

UR - http://www.scopus.com/inward/record.url?scp=84946826247&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84946826247&partnerID=8YFLogxK

M3 - Article

VL - 16

SP - 490

EP - 500

JO - Journal of Applied Clinical Medical Physics

JF - Journal of Applied Clinical Medical Physics

SN - 1526-9914

IS - 6

ER -